Shannon M. Blakey , J. Russ Vandermaas-Peeler , Jennifer Counts , Julie Croxford , Kristine L. Rae Olmsted , Phil Gant , Eric B. Elbogen , Kat Asman
{"title":"将退伍军人心理健康促进和自杀预防工作推向上游:THRiVE研究协议。","authors":"Shannon M. Blakey , J. Russ Vandermaas-Peeler , Jennifer Counts , Julie Croxford , Kristine L. Rae Olmsted , Phil Gant , Eric B. Elbogen , Kat Asman","doi":"10.1016/j.cct.2025.108100","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Transition from military to civilian life presents both opportunities and challenges. Although existing programs provide newly separated veterans (NSVs) with career transition support, these programs do not fully address psychosocial aspects of reintegrating into civilian life. This is problematic because the military transition is a time during which NSVs are at higher risk for mental health disorders and suicide. Behavioral Activation (BA), an evidence-based psychotherapy that holds potential for optimizing psychosocial well-being during the military transition, could be adapted into an upstream mental health promotion and suicide prevention program to fill this gap. This study involves a one-arm trial to pilot test a BA-based program, called <em>Transition Health and Resilience through Valued Experiences</em> (THRiVE), for NSVs.</div></div><div><h3>Methods</h3><div>Up to 40 NSVs will receive THRiVE delivered virtually to small groups by a veteran peer facilitator. Self-report assessments will be administered at baseline, immediately post-THRiVE, and 3 months after THRiVE. Primary outcomes assess program feasibility and acceptability. Secondary outcomes explore preliminary effects on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning. Consistent with community-based participatory research models, the investigative team is partnering with a veteran Advisor and a Community Advisory Board composed of veterans and veteran spouses.</div></div><div><h3>Conclusion</h3><div>If successful, this trial would point toward potential means for optimizing mental health outcomes during the military transition. Positive findings would lay groundwork for testing the efficacy of THRiVE in larger and diverse samples. This study is registered in <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> (<span><span>NCT06778278</span><svg><path></path></svg></span>).</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"158 ","pages":"Article 108100"},"PeriodicalIF":1.9000,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bringing veteran mental health promotion and suicide prevention efforts upstream: The THRiVE study protocol\",\"authors\":\"Shannon M. Blakey , J. Russ Vandermaas-Peeler , Jennifer Counts , Julie Croxford , Kristine L. Rae Olmsted , Phil Gant , Eric B. Elbogen , Kat Asman\",\"doi\":\"10.1016/j.cct.2025.108100\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Transition from military to civilian life presents both opportunities and challenges. Although existing programs provide newly separated veterans (NSVs) with career transition support, these programs do not fully address psychosocial aspects of reintegrating into civilian life. This is problematic because the military transition is a time during which NSVs are at higher risk for mental health disorders and suicide. Behavioral Activation (BA), an evidence-based psychotherapy that holds potential for optimizing psychosocial well-being during the military transition, could be adapted into an upstream mental health promotion and suicide prevention program to fill this gap. This study involves a one-arm trial to pilot test a BA-based program, called <em>Transition Health and Resilience through Valued Experiences</em> (THRiVE), for NSVs.</div></div><div><h3>Methods</h3><div>Up to 40 NSVs will receive THRiVE delivered virtually to small groups by a veteran peer facilitator. Self-report assessments will be administered at baseline, immediately post-THRiVE, and 3 months after THRiVE. Primary outcomes assess program feasibility and acceptability. Secondary outcomes explore preliminary effects on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning. Consistent with community-based participatory research models, the investigative team is partnering with a veteran Advisor and a Community Advisory Board composed of veterans and veteran spouses.</div></div><div><h3>Conclusion</h3><div>If successful, this trial would point toward potential means for optimizing mental health outcomes during the military transition. Positive findings would lay groundwork for testing the efficacy of THRiVE in larger and diverse samples. This study is registered in <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> (<span><span>NCT06778278</span><svg><path></path></svg></span>).</div></div>\",\"PeriodicalId\":10636,\"journal\":{\"name\":\"Contemporary clinical trials\",\"volume\":\"158 \",\"pages\":\"Article 108100\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-10-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contemporary clinical trials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1551714425002940\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714425002940","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Bringing veteran mental health promotion and suicide prevention efforts upstream: The THRiVE study protocol
Background
Transition from military to civilian life presents both opportunities and challenges. Although existing programs provide newly separated veterans (NSVs) with career transition support, these programs do not fully address psychosocial aspects of reintegrating into civilian life. This is problematic because the military transition is a time during which NSVs are at higher risk for mental health disorders and suicide. Behavioral Activation (BA), an evidence-based psychotherapy that holds potential for optimizing psychosocial well-being during the military transition, could be adapted into an upstream mental health promotion and suicide prevention program to fill this gap. This study involves a one-arm trial to pilot test a BA-based program, called Transition Health and Resilience through Valued Experiences (THRiVE), for NSVs.
Methods
Up to 40 NSVs will receive THRiVE delivered virtually to small groups by a veteran peer facilitator. Self-report assessments will be administered at baseline, immediately post-THRiVE, and 3 months after THRiVE. Primary outcomes assess program feasibility and acceptability. Secondary outcomes explore preliminary effects on mental health symptoms, risk factors for suicidal ideation, and psychosocial functioning. Consistent with community-based participatory research models, the investigative team is partnering with a veteran Advisor and a Community Advisory Board composed of veterans and veteran spouses.
Conclusion
If successful, this trial would point toward potential means for optimizing mental health outcomes during the military transition. Positive findings would lay groundwork for testing the efficacy of THRiVE in larger and diverse samples. This study is registered in ClinicalTrials.gov (NCT06778278).
期刊介绍:
Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.